Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Dermapharm Holding SE
Dermapharm makes and sells branded medicines that no longer have patent protection, plus healthcare products, and sells them mainly in Germany and across Europe.
Dermapharm is a German drugmaker that sells branded medicines whose original patents have expired. These are not fancy new drugs. They are familiar treatments — things like pain relievers, skin creams, cough medicines, and vitamin supplements — that people buy at the pharmacy under a brand name they recognize rather than as a cheap generic. Dermapharm also makes herbal and natural remedies and a range of other healthcare products, and it sells them internationally, with Germany as its home base.
The business works because a brand still sells even after the patent runs out. When a drug loses patent protection, any manufacturer can copy the recipe and sell it cheaply. But shoppers often stick with the name they know. Dermapharm buys or builds those brands, keeps the packaging and reputation intact, and earns a healthy margin that a plain generic maker cannot. It also makes some products itself, so it controls the manufacturing and can keep costs down. Customers are pharmacies and wholesalers, and ultimately the people buying a trusted brand off the shelf. Beyond the core branded medicines, Dermapharm has expanded into other areas. It produces herbal and plant-based remedies, and it has a contract manufacturing arm that makes drugs and supplements for other companies. That mix gives it several ways to earn money, so it is not leaning on a single blockbuster product. It also has a longer history in the pharmacy world: the company grew partly by acquiring well-known German brands and keeping them alive.
One thing worth watching is how much of the business depends on Germany and on prices set by the health system. Drug pricing in Europe is heavily regulated, and cheaper generics are always circling. But a strong brand plus in-house manufacturing is a real cushion. Dermapharm pays its shareholders a dividend, and it has used acquisitions to keep adding brands and reach. The simple story: it sells medicines people already trust, and trust is a durable thing to own.
Saved answer · last researched 12 Nov 2026